Barclays PLC Gilead Sciences, Inc. Put Options Transaction History

Barclays PLC

$327 Billion
Q2 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $5.41 Million - $6.6 Million	-75,600 Reduced 37.43%	126,400 $9.26 Million
Q4 2023 Feb 15, 2024	SELL	$73.27 - $83.09 $9.42 Million - $10.7 Million	-128,600 Reduced 38.9%	202,000 $16.4 Million
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $8.7 Million - $9.49 Million	-117,600 Reduced 26.24%	330,600 $24.8 Million
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $15.2 Million - $17.4 Million	200,600 Added 81.02%	448,200 $34.5 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $19.1 Million - $21.8 Million	247,600 New	247,600 $20.5 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $31.6 Million - $35.8 Million	486,400 Added 94.45%	1,001,400 $72.7 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $11.5 Million - $12.4 Million	170,000 Added 49.28%	515,000 $36 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $20 Million - $21.8 Million	315,000 Added 1050.0%	345,000 $23.8 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $4.69 Million - $5.35 Million	-78,200 Reduced 72.27%	30,000 $1.94 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $99,360 - $124,928	-1,600 Reduced 1.46%	108,200 $6.84 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $49 Million - $56.9 Million	-677,500 Reduced 86.05%	109,800 $8.45 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $11.9 Million - $15.2 Million	189,900 Added 31.79%	787,300 $58.9 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $2.01 Million - $2.21 Million	32,600 Added 5.77%	597,400 $38.8 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $10.1 Million - $11.2 Million	162,100 Added 40.25%	564,800 $35.8 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $8.88 Million - $9.96 Million	-143,600 Reduced 26.29%	402,700 $27.2 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $6.73 Million - $7.54 Million	-107,600 Reduced 16.46%	546,300 $35.5 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $11 Million - $14.4 Million	-182,500 Reduced 21.82%	653,900 $40.9 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $11.8 Million - $13.1 Million	165,800 Added 24.72%	836,400 $64.6 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $8.22 Million - $9.59 Million	126,700 Added 23.29%	670,600 $47.5 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $40 Million - $48.7 Million	-548,500 Reduced 50.21%	543,900 $41 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $9.93 Million - $11.7 Million	139,600 Added 14.65%	1,092,400 $78.3 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $68.7 Million - $81.4 Million	952,800	952,800 $77.2 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.77 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.36 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.27 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account